HYDROCORTISONE VALERATE OINTMENT

The Defense Logistics Agency awarded a fixed-price delivery order, SPE2DP-26-F-7678, to DMS Pharmaceutical Group Inc. (CAGE 1UNB0) for the supply of 20 treatment units of Hydrocortisone Valerate Ointment (NSN 6505012240177) under the base contract SPE2DX-25-D-9900, with a total contract value of $2,514.00. The award was issued on July 14, 2026, and delivery is required by July 29, 2026, to Fort Stewart, Georgia, with FOB destination terms placing full responsibility for transportation and product integrity on the contractor. The product must be packaged to support traceable transport, labeled with the contract number, delivery order number, Traceability Control Number W33RBS61950358, and applicable NDCs (00072-7800-60 and 51672-1292-03), though no specific barcoding or MIL-STD references are mandated. The awardee is certified as a small, small disadvantaged, and women-owned small business, triggering associated reporting obligations under federal procurement rules. Inspection and acceptance occur at the destination by the government, with conformity to contract specifications as the sole acceptance criterion. Payment is processed through the Defense Finance and Accounting Service in Columbus, Ohio, using payment code SL4701, with no electronic invoicing system specified. The contracting officer is Lisa Quinn, and administrative support is provided by Shairy M. Cartagena. While no detailed FAR clauses, special requirements, or evaluation factors are documented, the low-dollar-value, single-line-item nature of the order strongly indicates a lowest price technically acceptable basis for award. The NAICS code 424210 applies, reflecting pharmaceutical and botanical product merchant wholesaling, and the contract is categorized as a federal procurement under the Department of Defense.